|
|
|
41
|
13315
|
FENTANYL CITRATE 50MCG/ML INJ (RTM) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
24.85
|
2.4846
|
AMP
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
42
|
13315
|
FENTANYL CITRATE 50MCG/ML INJ (RTM)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
14.95
|
1.50
|
AMPG
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
13319
|
FENTANYL CITRATE 50MCG/ML INJ (MTP/COL)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
13.05
|
1.31
|
INJECTION
|
0
|
AMP
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
13319
|
FENTANYL CITRATE 50MCG/ML INJ (MTP) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
17.94
|
1.7941
|
AMP
|
0
|
BOX
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
1331K
|
FENTANYL CITRATE 50MCG/ML INJ (KWA/ATB)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
25.17
|
0.25
|
INJECTION
|
0
|
AMP
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2022-09-30
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
2022-03-30
|
|
|
|
41
|
1331K
|
FENTANYL CITRATE 50MCG/ML INJ (KWA) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
18.02
|
1.8022
|
AMP
|
0
|
BOX
|
KWA
|
KWALITY PHARMACEUTICALS
|
ATB
|
ANSA TRADING BARBADOS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
1331M
|
FENTANYL CITRATE 50MCG/ML INJ (SGH/COL)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X2ML
|
BQ
|
13.59
|
1.36
|
INJECTION
|
0
|
AMP
|
SGH
|
SEIGFRIED-HAMELN
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
40
|
13325
|
FENTANYL CITRATE 50MCG/ML INJ (RTM/PHA)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
27.37
|
2.74
|
INJECTION
|
0
|
VIAL
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
13325
|
FENTANYL CITRATE 50MCG/ML INJ (RTM) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
38.22
|
3.822
|
VIAL
|
0
|
BOX
|
RTM
|
PANPHARMA GMBH
|
PHA
|
PHARMACY SALES CARIBBEAN
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
40
|
13329
|
FENTANYL CITRATE 50MCG/ML INJ (MTP/COL)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
31.26
|
3.13
|
INJECTION
|
0
|
AMP
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2022-04-01
|
2024-03-31
|
|
IV
|
0
|
CENTRAL NERVOUS SYSTEM DRUGS
|
|
|
|
|
41
|
13329
|
FENTANYL CITRATE 50MCG/ML INJ (MTP) (BQ)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
42.41
|
4.2406
|
AMP
|
0
|
BOX
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
COL
|
COLLINS LTD
|
|
280808
|
OPIATE AGONISTS
|
2024-04-01
|
2026-03-31
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
42
|
1332F
|
FENTANYL CITRATE 50MCG/ML INJ (MTP)
|
FENTANYL CITRATE
|
FENTANYL CITRATE
|
10X10ML
|
BQ
|
50.23
|
5.02
|
AMPG
|
0
|
AMP
|
MTP
|
MARTINDALE PHARMACEUTICALS
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE AGONISTS
|
|
|
|
|
42
|
1332L
|
VERFEN 50MCG/ML INJ (VEV) FENTANYL
|
FENTANYL CITRATE
|
VERFEN
|
5X10ML
|
BQ
|
23.65
|
4.73
|
AMPG
|
0
|
BOX
|
VEV
|
VERVE HUMANCARE LABORATORIES
|
AHI
|
ARMSTRONG HEALTHCARE INC
|
|
280808
|
OPIATE AGONISTS
|
2026-04-01
|
|
|
IV
|
0
|
OPIATE AGONISTS
|
|